Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis. 1993

A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
Department of Medicine, University of Rochester School of Medicine and Dentistry, NY 14642.

BACKGROUND Oral anticoagulation is most frequently monitored using the prothrombin time, but an alternative approach is measurement of native, fully carboxylated, prothrombin antigen (NPA). We have correlated results of the prothrombin time and NPA with development of venous thrombosis or bleeding complications in a clinical trial of warfarin prophylaxis following total hip arthroplasty to determine the potential value of NPA measurement for monitoring oral anticoagulation. RESULTS Patients in one arm of a prospective, randomized trial received warfarin prophylactically beginning 10 to 14 days before total hip arthroplasty in a dose adjusted to prolong the international normalized ratio (INR) to 1.5 on the day of surgery and 2.5 after surgery. NPA was measured by ELISA, and the prothrombin time was measured using rabbit brain thromboplastin. Samples were tested from 97 patients, and data from 81 patients who had adequate venography were analyzed to correlate test results with occurrence of thrombosis. The prothrombin time and INR were less sensitive than NPA to the lowest intensities of anticoagulation, with the prothrombin time index increasing from 1.0 to 1.3 and the INR increasing from 1.0 to 2.0, whereas the NPA concentration decreased fourfold, from 200 to 50 micrograms/mL. There was little correlation between either the prothrombin time index or the INR and the development of thrombosis, whereas NPA concentrations were significantly higher on the day of surgery and on postoperative days 1, 3, 5, and 7 in patients who developed venous thrombosis. Higher concentrations of NPA were associated with an increased risk of venous thrombosis, but there was no relation between thrombosis and the prothrombin time index or INR. There was no significant correlation between surgical blood loss and prothrombin time index, INR, or NPA concentration. However, patients who received the largest number of transfusions on the day of surgery had significantly lower NPA concentrations than patients who required no transfusion. CONCLUSIONS These results indicate that the NPA concentration more accurately reflects the antithrombotic effect of warfarin than does prothrombin time and may be superior in monitoring prophylactic oral anticoagulation.

UI MeSH Term Description Entries
D007431 Intraoperative Complications Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure. Peroperative Complications,Surgical Injuries,Complication, Intraoperative,Complication, Peroperative,Injuries, Surgical,Complications, Intraoperative,Complications, Peroperative,Injury, Surgical,Intraoperative Complication,Peroperative Complication,Surgical Injury
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D005260 Female Females
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006622 Hip Prosthesis Replacement for a hip joint. Femoral Head Prosthesis,Femoral Head Prostheses,Hip Prostheses,Prostheses, Femoral Head,Prostheses, Hip,Prosthesis, Femoral Head,Prosthesis, Hip
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
August 1984, Blood,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
January 1990, Blood,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
January 2009, Clinical chemistry and laboratory medicine,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
December 1986, British journal of hospital medicine,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
February 2004, Thrombosis and haemostasis,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
January 2003, Pathophysiology of haemostasis and thrombosis,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
January 1990, Annales de biologie clinique,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
January 2008, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
March 2005, Clinical chemistry,
A Kornberg, and C W Francis, and V D Pellegrini, and K R Gabriel, and V J Marder
January 1979, Pathology,
Copied contents to your clipboard!